Patent ID: 11964963
Assignee: ASKAT INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC C

Claim 4:
5. A crystalline form of an HCl salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl} sulfonyl)azetidin-1-yl]ethan-1-ol, wherein the crystalline form is characterized by an XRPD pattern comprising peaks in terms of 2-Theta at 6.6, 13.2, 15.6, 16.0, 17.2, 17.4, 17.9, 18.9, 20.1, 22.1, 23.4, 26.6, and 27.0 degrees 2-Theta+/−0.2 degrees 2-Theta for each value.